About Tau

The future of heart care is adaptive, precise, and patient‑centered.

At Tau Medical, we bring together technology and expertise to lead that transformation.

Who we are

A medtech venture for structural heart care.

Tau Medical is a medtech venture dedicated to advancing catheter-based therapies for structural and electrophysiological heart diseases, conditions that affect millions of people worldwide.

Our proprietary technologies are designed to address serious unmet clinical needs and reshape the future of heart valve therapy.

$60M+

venture capital and government funding

50+

cardiologists, engineers, and clinical experts

3

offices in Korea, USA, and India

7

nationalities represented across our team

Vision

To redefine the standard of care in cardiovascular medicine, with Tau’s technologies included in international clinical guidelines within five years.

Mission

To serve human life by advancing innovative, minimally invasive, and life-saving cardiovascular technologies.

Integrity

We hold ourselves to the highest standards of ethical conduct, and build trust through honesty, transparency, and accountability.

Excellence

Driven by purpose and precision, we pursue excellence in bold achievements and in the smallest meaningful details.

Innovation

We strive for creative breakthroughs that challenge convention and redefine what is possible in cardiovascular care.

Pipeline

Two programs, one approach.

  • Pivot‑TRTranscatheter spacer for tricuspid regurgitation, with permanent and temporary devicesExplore Pivot‑TR
  • MTR ComboOne procedure for combined mitral and tricuspid regurgitationExplore MTR Combo

Manufacturing

Designed, built, and tested in-house.

Tau Medical operates its own cleanroom and assembly line in Korea, where finished devices are built, inspected, and packaged for clinical use. Keeping production in-house lets the engineering and clinical teams move from a design change to a tested device without waiting on outside vendors.

Cleanroom assembly at Tau MedicalAdobe Stock preview · not licensed
  • Finished device productionClinical-use devices are produced on site, not outsourced.
  • Cleanroom assemblyDevices are assembled and packaged under controlled conditions.
  • In-house prototypingDesign changes are built and evaluated on site.
  • Quality systemsProduction follows documented procedures and inspection records.

Team Tau

Everyone who builds Tau.

About 50 people across R&D, production, regulatory, quality, clinical and operations, building Tau together from our offices in Korea, the U.S. and India.

Board of Directors

  • Junehong Kim (Chairman)
  • Sichan Sung, MD
  • Andy Jang (Stassets Investment)
  • Dongyoul Choi (Stonebridge Ventures)
  • Vincent Jeong (Yuanta Investment)

Audit Committee

  • Seong geun Kim (PNU Tech. Holdings)

Join us in transforming heart care.

We are always looking for mission-driven people to push the boundaries of innovation.